Medicofarma Biotech

Medicofarma Biotech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicofarma Biotech (MDB.WA) as of Oct 9, 2026 is -525,900.00 PLN. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -1.48 M PLN — a change of -64.57% (higher).

EBITDA

-525,900.00PLN

YoY

-64.57%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicofarma Biotech is 2024 -525,900.00 PLN. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicofarma Biotech was 2023 -1.48 M PLN. It decreases by -64.57% higher compared to the previous year.

The Medicofarma Biotech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
110,000.00 PLN
Jan 1, 2018
120,000.00 PLN
Jan 1, 2019
-290,000.00 PLN
Jan 1, 2020
-570,000.00 PLN
Jan 1, 2021
660,000.00 PLN
Jan 1, 2022
171,800.00 PLN
Jan 1, 2023
-1.48 M PLN
Jan 1, 2024
-525,900.00 PLN
The Medicofarma Biotech EBITDA history
YEAREBITDAYoY
-525,900.00PLN-64.57%
-1.48 MPLN-964.03%
171,800.00PLN-73.97%
660,000.00PLN-215.79%
-570,000.00PLN+96.55%
-290,000.00PLN-341.67%
120,000.00PLN+9.09%
110,000.00PLN+1,000.00%
10,000.00PLN-200.00%
-10,000.00PLN—
Access this data via the Eulerpool API
Get Free API Key

Medicofarma Biotech Stock analysis

What does Medicofarma Biotech do? Medicofarma Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicofarma Biotech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicofarma Biotech is -525,900.00 PLN in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicofarma Biotech changed from -1.48 M PLN to -525,900.00 PLN, representing a -64.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Medicofarma Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Medicofarma Biotech historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Medicofarma Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Medicofarma Biotech